Fairfield University, Fairfield, CT, USA
Diabetes Educ. 2013 Jan-Feb;39(1):66-73. doi: 10.1177/0145721712465340. Epub 2012 Nov 13.
The purpose of the research was to investigate the impact of point-of-care (POC) A1C testing among patients with type 2 diabetes in a primary care setting.
This study used a pretest-posttest design with data from patient charts matched for age, sex, race, body mass index, insurance status, and the number of comorbidities. A random sample of charts of patients with type 2 diabetes in the primary care setting was reviewed 6 months and 3 months pre- and post-implementation of the POC A1C testing.
There was a significant difference in the number of A1Cs documented in the medical record pre- versus post-implementation of POC A1C. There was also a significant difference in A1C values pre- versus post-implementation. There was also a difference in the treatment changes pre- versus post-implementation of POC A1C.
Point-of-care A1C testing represents an opportunity for improved care of people with diabetes. The significance of this improvement will become more critical as the number of people with type 2 diabetes continues to increase.
本研究旨在探讨在初级保健环境中,即时检测(POC)糖化血红蛋白(A1C)测试对 2 型糖尿病患者的影响。
本研究采用了预-后测试设计,使用患者病历中的数据进行匹配,匹配因素包括年龄、性别、种族、体重指数、保险状况和合并症数量。随机抽取了初级保健环境中 2 型糖尿病患者的病历进行回顾,在实施 POC A1C 测试前、后的 6 个月和 3 个月进行了回顾。
在实施 POC A1C 测试前后,病历中记录的 A1C 数量存在显著差异。A1C 值在实施前后也存在显著差异。在实施 POC A1C 前后,治疗方案也存在差异。
即时检测 A1C 测试为改善糖尿病患者的治疗提供了机会。随着 2 型糖尿病患者人数的不断增加,这种改善的意义将变得更加关键。